Approved IV drug reduces lupus symptoms, clinical trial finds

An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...
Yahoo Finance

TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma

TAMPA, Fla., Feb. 2, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to ...
Forbes

Trump Balks At Declaring War For Venezuelan Drug Cartel Strikes: ‘We’re Just Going To Kill People’

President Donald Trump resisted the idea of making a declaration of war against Venezuelan drug cartels being targeted by U.S. military strikes, telling reporters Thursday “we’re gonna kill them” as ...
Becker's Hospital Review

FDA flags fatal risk from spinal injection of IV drug

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...
News Medical

Breakthrough in protein drug delivery could replace lengthy IV infusions

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
BMJ

Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial

Introduction The rapid worldwide spread of COVID-19 has caused a global health crisis. To date, symptomatic supportive care has been the most common treatment. It has been reported that the mechanism ...
Medscape

Prevention of Intravenous Drug Incompatibilities in an Intensive Care Unit

Drug therapy is a complex process with numerous parameters modulating its success and safety. The selection of a drug and the definition of its dosage regimen, which must consider both disease and ...
Forbes

FDA Greenlights Twice-A-Year HIV Prevention Drug

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...
FierceBiotech

Lundbeck ends subcutaneous migraine cohort after futility review, pivots to IV formulation

Lundbeck has stopped development of a subcutaneous formulation of its migraine drug Lu AG09222 as the Danish drugmaker switches its focus to intravenous delivery after seeing phase 2b data, delaying ...
The Scranton Times-Tribune

Gerrity’s implements blue lighting in bathrooms to thwart drug use

Supermarket shoppers’ eyes aren’t playing tricks on them. Gerrity’s has implemented new blue lighting in its bathrooms to thwart intravenous drug use. The restrooms at the Keyser Avenue location have ...
Nasdaq

CalciMedica initiated with a Buy at Lucid Capital

Lucid Capital initiated coverage of CalciMedica (CALC) with a Buy rating and $13 price target The company’s lead candidate, Auxora, is a potent and selective intravenous CRAC channel inhibitor in ...